breast cancer breast carcinoma
Conditions
Interventions
5-10ml of Iodined PolyEthyleneGlycol, brandname *TraceIT* will be left behind
just before FTC by stepwise instillation and coating the lumpectomy cavity
walls. All patients will undergo a CT at 3 ti
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: * Woman * Undergoing breast conserving surgery * Indication for radiotherapy * Full thickness closure (level 1 oncoplastic breast surgery) planned * Written informed consent
Exclusion criteria
Exclusion criteria: * Oncoplasty technique (level 2 Oncoplastic breast surgery) planned * need for adjuvant chemotherapy * Allergy for PEG * Allergy for Iodine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| primary endpoint: the Conformity Index (Cx) of target definition. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints: the distance between observers* target volumes (dCOM), target volumes, Cavity Visualisation Score, feasibility of the hydrogel marker instillation, stability of the hydrogel marker volume over time, adverse events, ease of use, motion of hydrogel marker/clips over time, the feasibility of patient positioning based on the hydrogel marker on cone beam computed tomography (CBCT) and planar kV images made on a conventional linac and a Cyberknife and the accuracy of this procedure compared to positioning based on the surgical clips. | — |
Countries
Netherlands
Outcome results
None listed